$29.44
-1.57 (-5.06%)
Open$31.00
Previous Close$31.01
Day High$31.00
Day Low$28.57
52W High$31.14
52W Low$14.59
Volume—
Avg Volume463.4K
Market Cap1.90B
P/E Ratio—
EPS$-3.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
20 analysts
Price Target
-23.9% upside
Current
$29.44
$29.44
Target
$22.40
$22.40
$12.72
$22.40 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 601.07M | 622.81M | 541.11M |
| Net Income | 107.25M | 120.49M | 94.92M |
| Profit Margin | 17.8% | 19.4% | 17.5% |
| EBITDA | 198.86M | 206.18M | 175.68M |
| Free Cash Flow | 71.76M | 51.92M | 65.95M |
| Rev Growth | +10.0% | +14.9% | +24.5% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |